APA (7th ed.) Citation

Mangu, C., Cossa, M., Ndege, R., Khosa, C., Leukes, V., de la Torre-Pérez, L., . . . Cox, H. (2024). Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: A randomized controlled trial (the EXULTANT trial). BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-09651-z

Chicago Style (17th ed.) Citation

Mangu, Chacha, et al. "Expanding Xpert MTB/RIF Ultra® and LF-LAM Testing for Diagnosis of Tuberculosis Among HIV-positive Adults Admitted to Hospitals in Tanzania and Mozambique: A Randomized Controlled Trial (the EXULTANT Trial)." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-09651-z.

MLA (9th ed.) Citation

Mangu, Chacha, et al. "Expanding Xpert MTB/RIF Ultra® and LF-LAM Testing for Diagnosis of Tuberculosis Among HIV-positive Adults Admitted to Hospitals in Tanzania and Mozambique: A Randomized Controlled Trial (the EXULTANT Trial)." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-09651-z.